Allied Biotech Corporation - Laporan Laba Rugi (TTM)

Allied Biotech Corporation
TW ˙ TPEX
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Allied Biotech Corporation menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 613 618 629 639 658 677 679 681 699 717 727 736 728 720 765 769 788 807 783 804
Change (%) 0.79 1.71 1.68 2.94 2.86 0.28 0.28 2.66 2.59 1.37 1.35 -1.08 -1.09 6.14 0.56 2.47 2.41 -3.00 2.78
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 369 377 383 389 404 419 427 434 440 446 454 462 468 474 527 522 535 549 501 523
Change (%) 2.15 1.55 1.53 3.87 3.73 1.87 1.84 1.30 1.29 1.85 1.81 1.28 1.26 11.10 -0.90 2.56 2.49 -8.70 4.50
% of Revenue 60.17 60.98 60.89 60.80 61.35 61.87 62.85 63.83 62.99 62.18 62.48 62.77 64.26 65.79 68.86 67.87 67.92 67.98 63.99 65.06
Gross Operating Profit 244 241 246 251 254 258 252 246 259 271 273 274 260 246 238 247 253 258 282 281
Change (%) -1.28 1.95 1.91 1.50 1.47 -2.30 -2.36 5.06 4.81 0.57 0.57 -5.06 -5.32 -3.39 3.79 2.28 2.23 9.10 -0.28
% of Revenue 39.83 39.02 39.11 39.20 38.65 38.13 37.15 36.17 37.01 37.82 37.52 37.23 35.74 34.21 31.14 32.13 32.08 32.02 36.01 34.94
SG&A 113 114 114 114 117 121 126 131 139 147 145 142 137 132 135 136 140 144 152 142
Change (%) 1.10 0.09 0.09 2.81 2.73 4.21 4.04 6.08 5.73 -1.45 -1.47 -3.80 -3.95 2.77 0.69 2.91 2.83 5.19 -6.09
% of Revenue 18.39 18.45 18.15 17.87 17.85 17.83 18.52 19.22 19.86 20.47 19.90 19.35 18.82 18.27 17.69 17.71 17.79 17.86 19.37 17.70
R&D 24 25 25 25 25 26 26 25 25 25 25 26 26 26 26 26 26 26 26 27
Change (%) 0.47 0.22 0.22 2.17 2.12 -0.80 -0.81 -1.52 -1.54 2.85 2.77 0.26 0.26 -1.59 0.26 0.73 0.73 -0.85 3.38
% of Revenue 3.99 3.97 3.92 3.86 3.83 3.80 3.76 3.72 3.57 3.43 3.48 3.53 3.57 3.62 3.36 3.35 3.29 3.24 3.31 3.33
OpEx 506 515 522 528 546 565 578 591 604 617 624 631 631 632 688 684 701 719 678 693
Change (%) 1.84 1.17 1.15 3.56 3.44 2.25 2.20 2.24 2.19 1.10 1.09 0.09 0.09 8.84 -0.54 2.56 2.49 -5.63 2.09
% of Revenue 82.54 83.41 82.96 82.53 83.03 83.50 85.14 86.77 86.42 86.08 85.86 85.64 86.65 87.69 89.91 88.93 89.01 89.08 86.67 86.08
Operating Income 107 103 107 112 112 112 101 90 95 100 103 106 97 89 77 85 87 88 104 112
Change (%) -4.19 4.43 4.24 0.01 0.01 -9.69 -10.73 5.41 5.13 2.99 2.90 -8.05 -8.75 -13.06 10.40 1.74 1.71 18.44 7.26
% of Revenue 17.46 16.59 17.04 17.47 16.97 16.50 14.86 13.23 13.58 13.92 14.14 14.36 13.35 12.31 10.09 11.07 10.99 10.92 13.33 13.92
Interest Expense -8 -9 -10 -10 -11 -11 -11 -12 -12 -12 -12 -13 -13 -13 -13 -13 -13 -14 -15 -16
Change (%) 7.83 6.96 6.50 4.86 4.63 1.75 1.72 0.49 0.48 3.83 3.69 1.20 1.19 -0.74 -1.35 5.00 4.76 6.26 9.25
% of Revenue -1.36 -1.46 -1.53 -1.60 -1.63 -1.66 -1.69 -1.71 -1.67 -1.64 -1.68 -1.72 -1.76 -1.80 -1.68 -1.65 -1.69 -1.73 -1.89 -2.01
Net Income 72 79 65 51 32 13 38 62 105 147 145 144 121 97 93 106 103 101 136 49
Change (%) 10.00 -17.91 -21.82 -37.22 -59.27 189.41 65.45 67.49 40.30 -1.01 -1.02 -16.13 -19.23 -4.65 13.86 -2.28 -2.33 34.96 -64.21
% of Revenue 11.78 12.86 10.38 7.98 4.87 1.93 5.56 9.18 14.97 20.47 19.99 19.53 16.56 13.52 12.15 13.75 13.12 12.51 17.41 6.06

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista